December 3, 2014 | The California Institute for Regenerative Medicine and Israel’s Center for R&D, MATIMOP, will cooperate to advance stem cell research and regenerative medicine. The agreement, which will be signed on December 5th, lays out the foundation for a potential Californian-Israeli stem cell research programs, with the goal of making it easier for researchers to obtain funding. At the signing of the agreement in San Francisco, MATIMOP will be represented Michel Hivert. MATIMOP is the executive agency of the Office of the Chief Scientist and is the national agency for research and development in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments